Rare cell detection of BRAF-V600E mutation in the patients with papillary thyroid carcinoma

Rare cell detection of BRAF-V600E mutation in the patients with papillary thyroid carcinoma

碩士 === 長庚大學 === 醫學生物技術暨檢驗學系 === 104

Bibliographic Details
Main Authors:	Kong Kit Leong, 梁港傑
Other Authors:	C. P. Tseng
Format:	Others
Language:	zh-TW
Published:	2016
Online Access:	http://ndltd.ncl.edu.tw/handle/32168897695336483608

Similar Items

BRAF V600E mutation detection for patients with papillary thyroid carcinoma by cell-direct PNA-PCR
by: Yu Ting Chen, et al.
Published: (2017)

Clinical significance of BRAF V600E mutation in low risk papillary thyroid carcinoma
by: He-Jiun Jiang, et al.
Published: (2018)

BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients.
by: Jian Sun, et al.
Published: (2016-01-01)

A thyroid gland with over 30 foci of papillary thyroid carcinoma with activating BRAF V600E mutation
by: Jill Pancer, et al.
Published: (2019-03-01)

Relationship between BRAF V600E and clinical features in papillary thyroid carcinoma
by: Changjiao Yan, et al.
Published: (2019-07-01)

Association between BRAF V600E Mutation and Ultrasound Features in Papillary Thyroid Carcinoma Patients with and without Hashimoto’s Thyroiditis
by: Qin Zhang, et al.
Published: (2017-07-01)

Predicting factors of central lymph node metastasis and BRAF V600E mutation in Chinese population with papillary thyroid carcinoma
by: Sheng Li Zhou, et al.
Published: (2021-07-01)

High Preponderance of BRAF V600E Mutation in Papillary Thyroid Carcinoma Among Filipinos: A Clinicopathologic Study
by: Gerard Anthony M. Espiritu, et al.
Published: (2019-01-01)

False-negative BRAF V600E mutation results on fine-needle aspiration cytology of papillary thyroid carcinoma
by: Se Hyun Paek, et al.
Published: (2017-11-01)

Deep Small RNA Sequencing of BRAF V600E Mutated Papillary Thyroid Carcinoma With Lymph Node Metastasis
by: Azliana Mohamad Yusof, et al.
Published: (2019-10-01)

Extended Antitumor Responseof a BRAF V600E Papillary Thyroid Carcinoma to Vemurafenib
by: Siraj M. Ali, et al.
Published: (2014-05-01)

BRAF V600E and lymph node metastases in papillary thyroid cancer
by: Pan Chen, et al.
Published: (2020-10-01)

Relevance and clinicopathologic relationship of BRAF V600E, TERT and NRAS mutations for papillary thyroid carcinoma patients in Northwest China
by: Meiling Huang, et al.
Published: (2019-07-01)

Evaluation of molecular diagnostic approaches for the detection of BRAF p.V600E mutations in papillary thyroid cancer: Clinical implications.
by: Artur Kowalik, et al.
Published: (2017-01-01)

BRAF in Papillary Thyroid Carcinoma
by: Salvatore Giovanni Lanzilotta, et al.
Published: (2007-01-01)

Associations of the BRAF(V600E) mutation with sonographic features and clinicopathologic characteristics in a large population with conventional papillary thyroid carcinoma.
by: Ah Young Park, et al.
Published: (2014-01-01)

Effect of BRAF<sup>V600E </sup>mutation on transcription and post-transcriptional regulation in a papillary thyroid carcinoma model
by: Guenther Simone M, et al.
Published: (2007-03-01)

The Clinical Manifestations and Specific Gene Expressions in Conventional Papillary Thyroid Carcinoma with BRAFV600E Mutation and BRAF Pseudogene
by: Shuai-Shuai Fu, et al.
Published: (2012)

Association between BRAF (V600E) mutation and clinicopathological features of papillary thyroid carcinoma: a Brazilian single-centre case series
by: Danielle Pessôa-Pereira, et al.
Published: (2019-03-01)

Clinical implications of the BRAF mutation in papillary thyroid carcinoma and chronic lymphocytic thyroiditis
by: Woon Won Kim, et al.
Published: (2018-01-01)

Cross-regulation between oncogenic BRAF(V600E) kinase and the MST1 pathway in papillary thyroid carcinoma.
by: Seong Jin Lee, et al.
Published: (2011-01-01)

Higher EU-TIRADS-Score Correlated with BRAF V600E Positivity in the Early Stage of Papillary Thyroid Carcinoma
by: Karolina Skubisz, et al.
Published: (2021-05-01)

BRAF V600E expression found in aggressive papillary thyroid carcinoma (PTC), lymph node metastasis, and extra-thyroid extension
by: Made Priska Rusmana, et al.
Published: (2018-10-01)

BRAFV600E mutation in anaplast thyroid carcinomas and multiple papillary thyroid carcinomas
by: Po-chin Tsai, et al.
Published: (2005)

Clinical effect of MUC1 and its relevance to BRAF V600E mutation in papillary thyroid carcinoma: a case–control study
by: Li Q, et al.
Published: (2018-05-01)

Prevalence of BRAF Mutation in Papillary Thyroid Cancer
by: Shatha Dmour, et al.
Published: (2016-12-01)

BRAF and KRAS mutations in papillary thyroid carcinoma in the United Arab Emirates.
by: Suhail Al-Salam, et al.
Published: (2020-01-01)

BRAF mutation in papillary carcinoma of the thyroid: Clinical implication and cytomorphology correlation
by: Kung-Jen Huang, et al.
Published: (2006)

VE1 Immunohistochemistry Improves the Limit of Genotyping for Detecting <i>BRAF</i><sup>V600E</sup> Mutation in Papillary Thyroid Cancer
by: Sonam Choden, et al.
Published: (2020-03-01)

BRAF Testing in Multifocal Papillary Thyroid Carcinoma
by: Hillary Z. Kimbrell, et al.
Published: (2015-01-01)

The role of BRAF V600 mutation in melanoma
by: Ascierto Paolo A, et al.
Published: (2012-07-01)

BRAF and NRAS Mutations in Papillary Thyroid Carcinoma and Concordance in BRAF Mutations Between Primary and Corresponding Lymph Node Metastases
by: Najla Fakhruddin, et al.
Published: (2017-07-01)

The Impact of BRAF Mutation on the Recurrence of Papillary Thyroid Carcinoma: A Meta-Analysis
by: Xin Li, et al.
Published: (2020-07-01)

BRAF mutation in progression and therapy of melanoma, papillary thyroid carcinoma and colorectal adenocarcinoma
by: Izabela Zaleśna, et al.
Published: (2016-05-01)

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas
by: Francesca Del Bufalo, et al.
Published: (2018-11-01)

A BRAF V600E Mutation in RET-Negative Medullary Thyroid Cancer
by: Richard J. Robbins, et al.
Published: (2020-01-01)

Coexistence of TERT Promoter Mutations and the BRAF V600E Alteration and Its Impact on Histopathological Features of Papillary Thyroid Carcinoma in a Selected Series of Polish Patients
by: Dagmara Rusinek, et al.
Published: (2018-09-01)

<i>Snail-1</i> Overexpression Correlates with Metastatic Phenotype in BRAF<sup>V600E</sup> Positive Papillary Thyroid Carcinoma
by: Katarzyna Wieczorek-Szukala, et al.
Published: (2020-08-01)

Preoperative detection of TERT promoter and BRAFV600E mutations in papillary thyroid carcinoma in high-risk thyroid nodules
by: Tatiana Marina Vieira Giorgenon, et al.
Published: (2019-03-01)

Analysis of NTRK1 gene rearrangement and BRAF gene mutation in papillary thyroid carcinoma
by: Chun-Liang Li, et al.
Published: (2004)

Cannot write session to /tmp/vufind_sessions/sess_glttg1t9t332qo0a9f1i713jq2